Exclusive-’No discussions’ over AstraZeneca-Bristol Myers deal, senior source says

A senior source has explicitly stated that there are no discussions currently taking place regarding a potential deal between AstraZeneca and Bristol Myers. This clarification follows reports suggesting a possible agreement between the two pharmaceutical entities. The source emphasizes that no such negotiations are occurring, effectively denying the rumors of a strategic merger or acquisition deal between AstraZeneca and Bristol Myers at this time, maintaining the current operational status of both companies.